Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- IMRN +16.2% (guidance), ERIC +10.6%, WBA +6.3%, SCHW +5.4%, GS +3.5%, BAC +2.5%, STT +1.7%, PNC +0.5%
Other news:
- WOLF +23.6% (receives $750 mln in proposed funding from U.S. CHIPS Act and additional $750 mln from investment group led by Apollo)
- PHX +5.1% (WhiteHawk Energy reiterates proposal to acquire PHX Minerals for $4/share)
- KEN +3.6% (announces updates on agreements by CPV to increase interests in two power plants)
- NIPG +3.5% (signs definitive agreement to acquire Young Will)
- OCUL +2.3% (Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI in Wet AMD)
- MPW +2.2% (releases finding of investigation Into short-seller allegations)
- MEG +2.1% (awarded $249 mln U.S. Army Corps of Engineers Environmental Services Contract)
- PRMW +2% (declares special dividend of $0.82 per share)
- BTBT +1.8% (acquires Enovum Data Centers for CAD $62.8 mln)
- PTCT +1.1% (FDA sets target regulatory action date)
- LUV +1% (comments on Elliott Management's Special Meeting request)
- ARGX +1% (Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions)
- JAZZ +0.9% (announces statistically significant overall survival and progression-free survival results for Zepzelca and atezolizumab combination)